Skip to main content
Premium Trial:

Request an Annual Quote

DNA Repair Licenses Predictive Breast Cancer Therapy Test from Helsinki Hospital

NEW YORK (GenomeWeb News) – The DNA Repair Company has licensed the exclusive North American rights to a test from Helsinki University Central Hospital that predicts how women with breast cancer will respond to a common chemotherapy drug.
 
The Boston-based company acquired the rights to the test through an agreement with Licentia, a Finnish technology transfer company. DNAR plans to use a variant of the NQO1 enzyme to create personalized medicine tests.
 
The NQO1 enzyme was shown in a Helsinki University study to protect cells against oxidative stress, the company said, and patients having one variant of the protein, NQO1*2, had worse survival chances when they were treated with an anthracycline-based chemotherapy compared with an alternative therapy.
 
Women in the study who possessed a double copy of the NQO1*2 variant in their genome had only a 17 percent survival rate while those with only a single copy or without the variant had a survival rate of 75 percent.
 
This was the only study so far to discover this effect, the company said, and independent studies must be conducted in order to develop a test.
 
DNAR CEO Daniel Paterson said the findings about the NQO1*2 variant are “highly significant and hold important promise for predicting clinical outcomes for cancer patients.”
 
Financial terms of the agreement were not released.
 

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.